RENAISSANCE TECHNOLOGIES LLC

Position in CLYM — Climb Bio, Inc.

CIK 1037389 NEW YORK, NY

Position in CLYM

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,512,808

+$1,024,303 QoQ

Shares Held

192,700

-11.3% QoQ

Ownership

0.336%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#37

of 108 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,579,858 across 312 Biotechnology names. CLYM ranks #117 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,512,808	192,700	-11.3%	Shares	Sole	2026-08-13
2026-03-31	$1,488,505	217,300	-32.2%	Shares	Sole	2026-05-14
2025-12-31	$1,282,400	320,600	-40.3%	Shares	Sole	2026-02-12
2025-09-30	$1,079,571	537,100	+8.4%	Shares	Sole	2025-11-13
2025-06-30	$614,420	495,500	-3.7%	Shares	Sole	2025-08-13
2025-03-31	$627,565	514,398	+38.2%	Shares	Sole	2025-05-14
2024-12-31	$670,140	372,300	+442.7%	Shares	Sole	2025-02-13
2024-09-30	$349,174	68,600	+85.4%	Shares	Sole	2024-11-13
2024-06-30	$263,070	37,000	+248.5%	Shares	Sole	2024-08-09
2024-03-31	$29,090	10,617	+0.1%	Shares	Sole	2024-05-13
2023-12-31	$28,628	10,603	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.